TOPS TOP Ships Inc. gains 15% Oct 2, 2018

Top Ships Inc. provides seaborne transportation services worldwide. It owns and operates medium range tanker vessels that transport crude oil, petroleum products, and bulk liquid chemicals. The company transports petroleum products and crude oil for the oil industry. As of December 31, 2016, it had a fleet of two chartered-in 49,737 deadweight ton (dwt) product/chemical tankers vessels, the M/T Stenaweco Energy and the M/T Stenaweco Evolution; two 39,208 dwt product/chemical tankers vessels, the M/T Eco Fleet and the M/T Eco Revolution; and two 49,737 dwt product/chemical tankers, the M/T Stenaweco Excellence and M/T Nord Valiant. The company was formerly known as Top Tankers Inc. and changed its name to Top Ships Inc. in December 2007. Top Ships Inc. was founded in 2000 and is based in Maroussi, Greece.http://www.priceseries.com/trade/TOPS-TOP-Ships-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2018091820181002.html

RLGT Radiant Logistics, Inc. gains 22% Oct 2, 2018

Radiant Logistics, Inc., a third party logistics company, provides multi-modal transportation and logistics services primarily in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services; and freight brokerage services, including truckload services, less than truckload services, and intermodal services. It also provides other value-added logistics services, such as customs brokerage, order fulfillment, inventory management, and warehouse and distribution services. The company offers its services to the consumer goods, food and beverage, manufacturing, and retail customers through a network of company-owned and strategic operating partner locations operating under the Radiant, Wheels, Airgroup, Adcom, DBA, and Service By Air brands. Radiant Logistics, Inc. was founded in 2001 and is headquartered in Bellevue, Washington.http://www.priceseries.com/trade/RLGT-Radiant-Logistics-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2018091220181002.html

QTRX Quanterix Corp. gains 23% Oct 2, 2018

http://www.priceseries.com/trade/QTRX-Quanterix-Corp-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018091420181002.html

OLLI Ollies Bargain Outlet Holdings, Inc. gains 26% Oct 2, 2018

Ollie's Bargain Outlet Holdings, Inc. operates as a retailer of brand name merchandise. The company offers food products, housewares, books and stationery products, bed and bath products, floor coverings, electronics, and toys; and other products, including hardware, personal health care, candy, clothing, sporting goods, pet products, luggage, automotive, seasonal, furniture, summer furniture, and lawn and garden. As of January 28, 2017, it operated 234 Ollie's Bargain Outlet locations across 19 states in the United States. The company was formerly known as Bargain Holdings, Inc. and changed its name to Ollie's Bargain Outlet Holdings, Inc. in March 2015. Ollie's Bargain Outlet Holdings, Inc. was founded in 1982 and is headquartered in Harrisburg, Pennsylvania.http://www.priceseries.com/trade/OLLI-Ollies-Bargain-Outlet-Holdings-Inc-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2018081720181002.html

MESO Mesoblast Limited gains 21% Oct 2, 2018

Mesoblast Limited develops cell-based medicines. The company has leveraged its proprietary technology platform based on specialized cells, known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular diseases, immune-mediated and inflammatory conditions, orthopedic disorders, and oncologic/hematologic conditions. The company's lead product candidates include MPC-150-IM, a Phase 3 product candidate under investigation for the treatment of chronic congestive heart failure; MPC-06-ID, a Phase 3 product candidate under investigation for the treatment of chronic low back pain due to disc degeneration; MSC-100-IV, a Phase 3 intravenously-delivered product candidate, which is developed for the treatment of acute graft versus host disease following allogeneic bone marrow transplantation; and MPC-300-IV, an intravenously-delivered immunomodulatory product candidate for the treatment of chronic inflammatory conditions, including biologic-refractory rheumatoid arthritis, and diabetic nephropathy, which is under Phase 2 trial. It has a collaboration agreement with JCR Pharmaceuticals Co., Ltd to offer TEMCELL HS. Inj., a product based on its proprietary mesenchymal lineage adult stem cell technology for the treatment of graft versus host disease. The company has operations in Australia, the United States, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited was founded in 2004 and is based in Melbourne, Australia.http://www.priceseries.com/trade/MESO-Mesoblast-Limited-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018091720181002.html

MBOT Microbot Medical Inc. gains 21% Oct 2, 2018

Microbot Medical Inc., a medical device company, engages in the research, design, development, and commercialization of micro-robotics medical technologies. Its ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel.http://www.priceseries.com/trade/MBOT-Microbot-Medical-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018091820181002.html

GHDX Genomic Health, Inc. gains 25% Oct 2, 2018

Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company offers the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the likelihood of breast cancer recurrence and chemotherapy benefit. It also provides the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer; the Oncotype DX prostate cancer test, which provides a genomic prostate score to predict disease aggressiveness in men with low risk disease, as well as used to enhance treatment decisions for prostate cancer patients in conjunction with the Gleason score or tumor grading; and Oncotype SEQ Liquid Select test, a non-invasive liquid biopsy test, which uses next-generation sequencing to identify and select actionable genomic alterations to quantify the presence and burden of cancer, as well as helps to predict the sensitivity or resistance to specific drugs for patients with certain late-stage cancers, such as lung, breast, colon, melanoma, ovarian, or gastrointestinal cancers. Its development stage pipeline products include Oncotype TRACK products for non-invasive tumor monitoring. The company offers its products through a network of distributors. Genomic Health, Inc. has a collaboration agreement with Epic Sciences, Inc. The company was founded in 2000 and is based in Redwood City, California.http://www.priceseries.com/trade/GHDX-Genomic-Health-Inc-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2018081720181002.html

CHMA Chiasma, Inc. gains 26% Oct 2, 2018

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.http://www.priceseries.com/trade/CHMA-Chiasma-Inc-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2018091320181002.html

AKCA Akcea Therapeutics, Inc. gains 18% Oct 2, 2018

N/Ahttp://www.priceseries.com/trade/AKCA-Akcea-Therapeutics-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2018091820181002.html

TRVG trivago N.V. - American Deposit gains 19% Oct 1, 2018

N/Ahttp://www.priceseries.com/trade/TRVG-trivago-NV---American-Deposit-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018091420181001.html

SBH Sally Beauty Holdings, Inc. gains 16% Oct 1, 2018

Sally Beauty Holdings, Inc., together with its subsidiaries, operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply segment offers beauty products, including hair color and care, skin and nail care, beauty sundries, and styling tools for retail customers and salon professionals. This segment also provides products under third-party brands, such as Clairol, CHI, China Glaze, OPI, and Conair, as well as exclusive-label merchandise. As of September 30, 2016, it operated 3,763 company-operated retail stores under the Sally Beauty banner in the United States, Canada, Mexico, Chile, Colombia, Peru, the United Kingdom, Ireland, Belgium, France, Germany, the Netherlands, and Spain; and 18 franchised stores in the United Kingdom, Belgium, and certain other European countries. The Beauty Systems Group segment offers professional beauty products, including hair color and care, skin and nail care, beauty sundries, and styling tools directly to salons and salon professionals through its sales force, as well as through company-operated and franchised stores. This segment also sells products under third-party brands, such as Paul Mitchell, Wella, Sebastian, Goldwell, Joico, and Aquage. This segment had 1,174 company-operated stores under the CosmoProf banner in the United States and Canada, as well as 164 franchised stores in the United States, Canada, Mexico, and certain European countries. The company also distributes its products through full-service/exclusive distribution, open-line distribution, directly, and mega-salon stores. Sally Beauty Holdings, Inc. was founded in 1964 and is headquartered in Denton, Texas.http://www.priceseries.com/trade/SBH-Sally-Beauty-Holdings-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018090420181001.html

MRNS Marinus Pharmaceuticals, Inc. gains 23% Oct 1, 2018

Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. The company is developing ganaxolone, a small molecule, which is in Phase III clinical trials to treat adults with refractory focal onset epileptic seizures; and is in Phase II clinical trials for the treatment of genetic orphan disorders, as well as is in Phase II clinical trial to treat Fragile X Syndrome, an orphan indication. The company is also developing ganaxolone IV formulation to treat status epilepticus. Marinus Pharmaceuticals, Inc. has a collaboration agreement with NovaMedica, LLC; and license agreement with Purdue Neuroscience Company. The company was founded in 2003 and is based in Radnor, Pennsylvania.http://www.priceseries.com/trade/MRNS-Marinus-Pharmaceuticals-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018091320181001.html

MIDD The Middleby Corporation gains 21% Oct 1, 2018

The Middleby Corporation designs, manufactures, markets, distributes, and services commercial foodservice, food processing, and residential kitchen equipment in the United States, Canada, Asia, Europe, the Middle East, and Latin America. Its Commercial Foodservice Equipment Group segment offers cooking and warming equipment for quick-service restaurants, full-service restaurants, convenience stores, retail outlets, hotels, and other institutions. This segment provides conveyor, combi, convection, baking, proofing, deck, speed cooking, and hydrovection ovens; and ranges, fryers, rethermalizers, steam cooking equipment, warming equipment, heated cabinets, charbroilers, ventless cooking systems, kitchen ventilation, induction cooking equipment, countertop cooking equipment, toasters, professional refrigerators, blast chillers, coldrooms, ice machines, freezers, and beverage dispensing equipment. The company's Food Processing Equipment Group segment offers processing solutions for customers producing hot dogs, dinner sausages, poultry, and lunchmeats, as well as muffins, cookies, and bread. This segment offers batch, baking, proofing, conveyor, and continuous processing ovens; frying systems and automated thermal processing systems; grinders, slicers, emulsifiers, mixers, blenders, battering and breading equipment, water cutting systems, food presses, and forming equipment; and various food safety, food handling, freezing, and packaging equipment. Its Residential Kitchen Equipment Group segment manufactures, sells, and distributes kitchen equipment comprising ranges, cookers, stoves, ovens, refrigerators, dishwashers, microwaves, cooktops, wine coolers, ice machines, and ventilation and outdoor equipment for the residential market. The company was formerly known as Middleby Marshall Oven Company and changed its name to The Middleby Corporation in 1985. The Middleby Corporation was founded in 1888 and is based in Elgin, Illinois.http://www.priceseries.com/trade/MIDD-The-Middleby-Corporation-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018080620181001.html

IPCI Intellipharmaceutics International Inc. gains 767% Oct 1, 2018

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada. It develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company's lead product is Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for attention deficit hyperactivity disorders. It also develops Rexista Oxycodone, an abuse and alcohol-deterrent controlled-release oral formulation for the relief of pain; Regabatin XR and Lyrica pregabalin extended-release capsules for the management of neuropathic pain; Effexor XR, an extended-release capsule for oral administration to treat depression; and Protonix, a delayed-release capsule for oral administration to treat gastroesophageal reflux disease. In addition, the company offers Glucophage XR, an oral antihyperglycemia drug to treat type 2 diabetes; Seroquel XR, an oral psychotropic agent for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; Lamictal XR, an anticonvulsant drug to terat epilepsy; Keppra XR, an antiepileptic drug for the treatment of partial onset seizures in patients with epilepsy; and Pristiq, a selective serotonin and norepinephrine reuptake inhibitor to treat major depressive disorder. Further, it provides Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Intellipharmaceutics International Inc. has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.http://www.priceseries.com/trade/IPCI-Intellipharmaceutics-International-Inc-stock-gains-767-percent-a-Trade-Record-by-priceSeries-2018090620181001.html

FTR Frontier Communications Corporation gains 18% Oct 1, 2018

Frontier Communications Corporation provides communications services to residential, business, and wholesale customers in the United States. It offers broadband, video, voice, and other services and products through a combination of fiber and copper based networks to residential customers. The company also provides broadband, Ethernet, traditional circuit-based, data and optical transport, and voice services, as well as Multiprotocol Label Switching and Time Division Multiplexing services to small business, medium business, and larger enterprises, as well as sells customer premise equipment. In addition, it offers 24/7 technical support; wireless broadband services in selected markets; and frontier secure suite of products, including computer security, cloud backup and sharing, identity protection, and equipment insurance. Further, the company provides satellite TV video services; voice services, including data-based VoIP, and long distance and voice messaging services; and a package of communications services. Additionally, it offers a range of access services that allow other carriers to use facilities to originate and terminate their local and long distance voice traffic. As of December 31, 2016, it served approximately 5.4 million customers and 4.3 million broadband subscribers in 29 states. The company was formerly known as Citizens Communications Company and changed its name to Frontier Communications Corporation in July 2008. Frontier Communications Corporation was founded in 1927 and is based in Norwalk, Connecticut.http://www.priceseries.com/trade/FTR-Frontier-Communications-Corporation-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2018090720181001.html

CVRS Corindus Vascular Robotics, Inc. gains 24% Oct 1, 2018

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force and distributor relationships in the United States and internationally. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. The company is headquartered in Waltham, Massachusetts.http://www.priceseries.com/trade/CVRS-Corindus-Vascular-Robotics-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2018090720181001.html